Steris

Health Care Health Care Equipment Dublin, Ireland Last filing May 29, 2026 · FY2026

                    Revenue
                    FY2026
                
$5.9B
                    3y CAGR +9.4%
                    
                    P60
                    
                    +8.7%
                    
                    Net income
                    FY2026
                
$782.3M
                    Net margin +13.2%
                    
                    P60
                    
                    +27.3%
                    
                    Total assets
                    FY2026
                
$10.7B
                    ROA +7.3%
                    
                    P80
                    
                    +5.8%
                    
                    Operating cash flow
                    FY2026
                
$1.3B
                    FCF margin +16.4%
                    
                    P80
                    
                    +16.8%

10 yrs · FY2017–FY2026 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s total assets.

Balance Sheet

Assets, liabilities, and equity

27 accounts · 10 years

Total assets $10.7B

Total liabilities $3.5B

Shareholders equity $7.2B

Account	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Assets
Cash and Cash Equivalents	4.1%	1.7%	1.9%	1.9%	3.0%	3.4%	5.9%	4.3%	3.9%	—
Accounts Receivable	10.2%	10.3%	9.1%	8.0%	7.0%	9.3%	10.8%	11.1%	10.2%	—
Inventory	5.9%	5.7%	6.1%	5.6%	5.0%	4.8%	4.6%	4.1%	4.0%	—
Prepaid Expenses	2.1%	2.0%	1.6%	1.6%	1.4%	1.0%	1.0%	1.2%	1.0%	—
Total Current Assets	22.3%	19.7%	25.9%	18.6%	16.4%	18.4%	22.3%	20.8%	19.0%	—
Property,Plant and Equipment	20.1%	19.3%	16.0%	15.1%	13.6%	18.8%	20.5%	20.3%	19.4%	—
Operating Lease Assets	1.4%	1.5%	1.6%	1.5%	1.6%	2.3%	2.4%	0.0%	—	—
Goodwill	39.1%	40.4%	36.8%	35.8%	38.6%	46.0%	43.4%	45.8%	46.8%	—
Intangible Assets	15.1%	18.3%	19.2%	19.2%	29.1%	13.7%	10.4%	11.9%	14.0%	—
Other Noncurrent Assets	2.0%	0.8%	0.6%	9.8%	0.6%	0.8%	1.0%	1.2%	0.8%	—
Total Assets	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	—
Liabilities
Accounts Payable	3.2%	2.8%	2.3%	2.4%	2.0%	2.4%	2.8%	3.0%	2.6%	—
Accrued Liabilities	6.1%	5.7%	4.5%	4.2%	4.5%	6.1%	6.2%	6.2%	5.0%	—
Current Portion of Long Term Debt	1.1%	1.2%	0.8%	0.6%	1.3%	0.0%	—	—	—	—
Operating Lease Liabilities	0.3%	0.3%	0.3%	0.3%	0.3%	0.3%	—	—	—	—
Total Current Liabilities	10.7%	10.1%	8.4%	8.0%	8.1%	8.8%	9.3%	9.2%	7.7%	—
Long Term Debt	16.9%	18.9%	28.2%	27.9%	25.8%	25.1%	21.2%	23.3%	25.3%	—
Operating Lease Liabilities Noncurrent	1.1%	1.2%	1.3%	1.3%	1.4%	2.0%	2.1%	0.0%	—	—
Deferred Tax Liabilities	3.6%	4.0%	4.3%	5.7%	6.8%	3.6%	3.0%	3.0%	3.1%	—
Other Noncurrent Liabilities	0.7%	0.6%	0.6%	0.9%	0.7%	1.3%	1.7%	1.7%	2.1%	—
Total Liabilities	33.0%	34.8%	42.9%	43.8%	42.7%	40.8%	37.2%	37.2%	38.1%	—
Equity
Common Stock	39.9%	43.6%	41.1%	41.5%	41.5%	30.5%	36.5%	39.4%	39.4%	—
Retained Earnings	28.1%	24.4%	18.9%	17.7%	17.5%	29.5%	30.4%	26.4%	22.0%	—
Accumulated Other Comprehensive Income	-1.1%	-2.9%	-3.0%	-3.0%	-1.8%	-0.9%	-4.3%	-3.1%	0.2%	—
Total Stockholders Equity	66.9%	65.1%	57.0%	56.2%	57.2%	59.0%	62.6%	62.6%	61.6%	—
Noncontrolling Interest	0.1%	0.1%	0.1%	0.1%	0.1%	0.2%	0.2%	0.2%	0.2%	—
Total Liabilitiesand Equity	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	—

Income Statement

Revenue, expense, and profitability

18 accounts · 10 years

Revenue $5.9B

Operating income $1.1B

Net income $782.3M

Account	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
IncomeStatement
Revenues Total Revenue	55.3%	53.8%	46.4%	41.9%	37.0%	47.3%	55.9%	54.8%	50.4%	—
Expenses Cost of Revenue	30.8%	30.1%	26.4%	23.6%	20.5%	26.8%	31.5%	31.7%	29.4%	—
Other Income Expense Gross Profit	24.5%	23.7%	20.0%	18.3%	16.5%	20.4%	24.3%	23.2%	21.0%	—
Expenses Research and Development	1.1%	1.1%	0.9%	0.9%	0.8%	1.0%	1.2%	1.2%	1.2%	—
Expenses Selling,General and Administrative	13.1%	13.1%	11.3%	10.1%	11.5%	11.1%	13.2%	13.2%	12.2%	—
Expenses Restructuring and Asset Impairment	0.0%	0.5%	0.2%	0.0%	0.0%	-0.0%	0.0%	0.6%	0.0%	—
Expenses Other Operating Expenses	0.0%	0.5%	0.0%	—	—	—	—	—	—	—
Expenses Operating Expenses	14.2%	15.1%	12.5%	11.0%	12.3%	12.1%	14.4%	15.1%	13.3%	—
Other Income Expense Operating Income	10.3%	8.5%	7.6%	7.3%	4.2%	8.3%	9.9%	8.1%	7.7%	—
Other Income Expense Interest Expense	0.6%	0.9%	1.3%	1.0%	0.8%	0.6%	0.7%	0.9%	1.0%	—
Other Income Expense Other Income/expense	0.1%	0.2%	0.1%	-0.0%	-0.2%	0.1%	0.0%	0.1%	0.1%	—
Other Income Expense Income Before Tax	9.8%	7.8%	6.4%	6.3%	3.2%	7.9%	9.2%	7.3%	6.8%	—
Income Tax Income Tax Expense	2.4%	1.8%	1.4%	1.1%	0.7%	1.8%	1.7%	1.3%	1.2%	—
net Income Other Items Below Tax	-0.0%	0.0%	-1.6%	-4.2%	-0.4%	0.0%	-0.0%	-0.0%	-0.0%	—
net Income net Income	7.3%	6.1%	3.4%	1.0%	2.1%	6.0%	7.5%	6.0%	5.6%	—
net Income Comprehensive Income	9.0%	6.4%	3.3%	-0.0%	0.8%	8.7%	6.1%	2.7%	10.4%	—
Earnings Per Share Basic Eps	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—
Earnings Per Share Diluted Eps	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Cash Flow Statement

Operating, investing, and financing flows

20 accounts · 10 years

Operating cash flow $1.3B

Investing cash flow $-512.5M

Financing cash flow $-568.2M

Account	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
CashFlow
Operating Activities net Income	7.3%	6.1%	3.4%	1.0%	2.1%	6.0%	7.5%	6.0%	5.6%	—
Operating Activities Depreciation and Amortization	4.5%	4.7%	5.2%	5.2%	5.4%	3.3%	3.6%	4.5%	3.4%	—
Operating Activities Stock Based Compensation	0.6%	0.6%	0.5%	0.4%	0.5%	0.4%	0.4%	0.5%	0.4%	—
Operating Activities Deferred Income Taxes	-0.2%	-0.8%	-1.2%	-1.7%	-0.9%	0.1%	0.2%	-0.1%	-0.5%	—
Operating Activities Changes In Operating Assets and Liabilities	0.3%	0.7%	-1.3%	-2.3%	-1.3%	0.3%	-0.9%	0.2%	-1.1%	—
Operating Activities Other Non Cash Items	-0.0%	0.1%	2.2%	4.5%	0.2%	0.4%	0.0%	-0.4%	0.9%	—
Operating Activities net Cash From Operating Activities	12.5%	11.3%	8.8%	7.0%	6.0%	10.5%	10.9%	10.6%	8.8%	—
Investing Activities Capital Expenditures	-3.4%	-3.6%	-3.3%	-3.3%	-2.5%	-3.6%	-4.0%	-3.7%	-3.2%	—
Investing Activities Business Acquisitions	-0.2%	-0.5%	-4.9%	-0.4%	-4.8%	-13.8%	-2.0%	-0.3%	-0.9%	—
Investing Activities Purchases of Investments	-1.2%	-0.1%	-0.0%	0.0%	0.0%	-0.1%	0.0%	-0.1%	0.0%	—
Investing Activities Other Investing Activities	0.1%	8.1%	0.2%	0.2%	1.5%	-0.0%	0.1%	-0.1%	0.2%	—
Investing Activities net Cash From Investing Activities	-4.8%	3.8%	-8.0%	-3.5%	-5.8%	-17.6%	-5.9%	-4.2%	-3.9%	—
Financing Activities Proceeds From Debt	0.0%	-4.4%	1.6%	2.2%	15.8%	7.9%	-0.5%	-0.5%	0.6%	—
Financing Activities Repayment of Debt	0.0%	-6.3%	-0.5%	-1.4%	-6.3%	-0.5%	0.0%	-1.7%	-4.3%	—
Financing Activities Repurchase of Common Stock	-2.2%	-2.1%	-0.1%	-2.9%	-0.5%	-0.2%	-0.9%	-1.6%	-1.3%	—
Financing Activities Dividends Paid	-2.3%	-2.2%	-1.8%	-1.7%	-1.4%	-2.0%	-2.3%	-2.2%	-2.0%	—
Financing Activities Other Financing Activities	-0.9%	-0.6%	0.1%	-0.8%	-6.6%	0.1%	0.7%	0.2%	0.1%	—
Financing Activities net Cash From Financing Activities	-5.3%	-15.5%	-0.8%	-4.6%	1.0%	5.3%	-3.0%	-5.8%	-6.8%	—
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%	0.0%	-0.0%	-0.1%	-0.1%	0.3%	-0.2%	-0.2%	0.4%	—
Cash Reconciliation net Change In Cash	2.5%	-0.3%	-0.0%	-1.3%	1.1%	-1.5%	1.8%	0.4%	-1.6%	—

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years

Ratio	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Profitability
Gross margin	+44.2%	+44.0%	+43.2%	+43.7%	+44.6%	+43.2%	+43.6%	+42.2%	+41.7%	+39.3%
Operating margin	+18.6%	+15.9%	+16.3%	+17.4%	+11.3%	+17.6%	+17.7%	+14.8%	+15.3%	+8.7%
Net margin	+13.2%	+11.3%	+7.4%	+2.4%	+5.8%	+12.8%	+13.5%	+10.9%	+11.1%	+4.2%
FCF margin	+16.4%	+14.3%	+11.9%	+8.7%	+9.4%	+14.5%	+12.4%	+12.6%	+11.2%	+9.6%
Growth
Revenue CAGR (3y)	+9.4%	+8.9%	+18.3%	+14.4%	+14.9%	+5.9%	+5.1%	—	—	—
Returns
ROE	+10.9%	+9.3%	+6.0%	+1.8%	+3.7%	+10.2%	+12.0%	+9.6%	+9.1%	—
ROA	+7.3%	+6.1%	+3.4%	+1.0%	+2.1%	+6.0%	+7.5%	+6.0%	+5.6%	—
ROIC	+9.5%	+7.9%	+7.1%	+7.2%	+4.0%	+7.9%	+10.4%	+8.2%	+7.6%	—
Liquidity
Current ratio	2.09x	1.96x	3.08x	2.33x	2.04x	2.10x	2.40x	2.27x	2.48x	—
Quick ratio	1.34x	1.19x	1.31x	1.25x	1.24x	1.44x	1.80x	1.69x	1.83x	—
Leverage
D/E	0.49x	0.53x	0.75x	0.78x	0.75x	0.69x	0.59x	0.59x	0.62x	—
Interest coverage	18.15x	10.04x	5.79x	7.33x	5.34x	14.75x	13.33x	9.14x	7.90x	5.08x
Efficiency
Asset turnover	0.55x	0.54x	0.46x	0.42x	0.37x	0.47x	0.56x	0.55x	0.50x	—
Cash conversion cycle	+100d	+106d	+124d	+118d	+124d	+104d	+92d	+87d	+90d	—

Valuation

Price against fundamentals

FY2026 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Steris

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history